Work

Covid-19: Diagnostic Methods and Recent Advances in Treatment

Year: 2026
Type: article
Abstract: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The emergence of SARS-CoV-2 stimulated rapid development of molecular diagnostics, rapid antigen tests, serological assays, imaging approaches and emerging point-of-care technologies. Accurate diagnosis supports clinical management, infection-control decisions, surveillance and timely identification of patients who may benefit from antiviral therapy. Nucleic-acid amplification tests, particularly reverse transcription polymerase chain reaction (RT-PCR), remain important laboratory methods for detecting viral RNA, while rapid antigen tests provide faster results and are useful for point-of-care and self-testing. Serological assays detect host antibodies and have more limited roles in early diagnosis. Newer approaches include reverse transcription loop-mediated isothermal amplification (RT-LAMP), CRISPR-based detection, biosensors, microfluidic platforms and multiplex respiratory pathogen assays. Treatment has evolved from predominantly supportive care toward risk- and severity-based management. Antiviral therapy is most relevant during the early viral-replication phase in patients at increased risk of progression, while corticosteroids and selected immunomodulators are used mainly in appropriately selected patients with severe or critical disease. Nirmatrelvir/ritonavir and remdesivir are important antiviral options in current clinical guidance, whereas molnupiravir has a more restricted role. Supportive respiratory care, oxygen therapy and management of complications remain essential. This review summarizes established and emerging diagnostic methods, current therapeutic strategies, limitations, and future directions in COVID-19 management.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7228292877
FWCI:
Cites:
Cited by:
Related to: 10